rsu 1172 has been researched along with misonidazole in 1 studies
*Misonidazole: A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. [MeSH]
*Misonidazole: A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. [MeSH]
| Studies (rsu 1172) | Trials (rsu 1172) | Recent Studies (post-2010) (rsu 1172) | Studies (misonidazole) | Trials (misonidazole) | Recent Studies (post-2010) (misonidazole) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1,562 | 139 | 210 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, I; Deacon, JM; Holliday, SB; Jenkins, TC | 1 |
1 other study(ies) available for rsu 1172 and misonidazole
| Article | Year |
|---|---|
Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
Topics: Animals; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Radiation-Sensitizing Agents | 1986 |